文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

接受有效抗逆转录病毒治疗且计划经阴道分娩的HIV阳性女性的妊娠结局

Outcome of pregnancy in HIV-positive women planned for vaginal delivery under effective antiretroviral therapy.

作者信息

Islam S, Oon V, Thomas P

机构信息

Department of Obstetrics and Gynaecology, Newham University Hospital, London, UK.

出版信息

J Obstet Gynaecol. 2010 Jan;30(1):38-40. doi: 10.3109/01443610903383358.


DOI:10.3109/01443610903383358
PMID:20121502
Abstract

This retrospective cohort study was conducted at Newham University Hospital, London to investigate maternal outcome of planned vaginal delivery as well as rate of maternal-to-child transmission. Between June 2004 and June 2006, 23 (16%) women of 144 HIV-infected pregnant women opted for planned vaginal delivery. Offer of vaginal delivery was based on maternal HIV RNA count <50 cells/ml around 36 weeks' gestation. All women received antiretroviral therapy. Fifteen (65%) women achieved vaginal delivery. Babies were followed up over 18 months. All babies had antiretroviral prophylaxis. No babies were breast-fed. There was no report of maternal-to-child transmission in any of these babies. Our study suggests that planned vaginal delivery could be safe with antiretroviral therapy in pregnancy, optimal intrapartum care, viral load of <1000 copies/ml at delivery, retroviral prophylaxis for babies and avoidance of breast-feeding.

摘要

这项回顾性队列研究在伦敦的纽汉大学医院开展,旨在调查计划阴道分娩的产妇结局以及母婴传播率。在2004年6月至2006年6月期间,144名感染HIV的孕妇中有23名(16%)选择了计划阴道分娩。阴道分娩的提议基于妊娠36周左右产妇的HIV RNA计数<50个细胞/毫升。所有女性均接受了抗逆转录病毒治疗。15名(65%)女性成功实现阴道分娩。对婴儿进行了18个月以上的随访。所有婴儿均接受了抗逆转录病毒预防治疗。没有婴儿进行母乳喂养。这些婴儿中均未报告母婴传播情况。我们的研究表明,在孕期进行抗逆转录病毒治疗、提供最佳的产时护理、分娩时病毒载量<1000拷贝/毫升、对婴儿进行逆转录病毒预防治疗以及避免母乳喂养的情况下,计划阴道分娩可能是安全的。

相似文献

[1]
Outcome of pregnancy in HIV-positive women planned for vaginal delivery under effective antiretroviral therapy.

J Obstet Gynaecol. 2010-1

[2]
[Mode of delivery of HIV-infected women: a retrospective study of 358 pregnancies followed in the same hospital between 2000 and 2004].

Gynecol Obstet Fertil. 2006-4

[3]
Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.

Obstet Gynecol. 2007-6

[4]
Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.

HIV Med. 2009-3

[5]
Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.

AIDS. 2008-1-11

[6]
Voluntary counselling and testing (VCT) uptake, nevirapine use and infant feeding options at the University of Nigeria Teaching Hospital.

J Obstet Gynaecol. 2008-4

[7]
[Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].

Ned Tijdschr Geneeskd. 2004-10-9

[8]
Pregnancy outcome among HIV positive women receiving antenatal HAART versus untreated maternal HIV infection.

J Coll Physicians Surg Pak. 2011-6

[9]
Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.

Pediatrics. 2007-4

[10]
Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

PLoS Med. 2007-8

引用本文的文献

[1]
The Cost-Effectiveness of HIV/STI Prevention in High-Income Countries with Concentrated Epidemic Settings: A Scoping Review.

AIDS Behav. 2022-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索